Latest Market Expansion News

Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.

Harvest Technology Group reported a 19% improvement in normalized EBITDA for Q3 FY25 alongside a $1.6 million capital raise, reinforcing its strategic plan to achieve profitability by FY27.

Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.

UNITH Ltd reports a 9.3% rise in Q3 FY25 cash receipts driven by its B2C subscription surge and a landmark pharmaceutical contract, alongside strategic platform upgrades and leadership changes.

Oakridge International Limited reported strong operational and financial progress for Q1 2025, highlighting increased trading income, positive cash flow, and a robust sales pipeline in healthcare IoT technology despite ongoing legal discussions.

Stakk Limited reports a staggering 2,533% quarter-on-quarter increase in annual recurring revenue to $472k, fueled by its acquisition of US-based Radical DBX and rapid expansion in Embedded Finance across Australia and the US.

Rare Foods Australia has secured shareholder approval to voluntarily delist from the ASX, while implementing significant cost reductions and achieving record growth in its Subsea Estate wine brand.

BPH Global Ltd has raised $609,000 through a targeted placement and made significant strides in its Indonesian seaweed venture, including binding offtake agreements and R&D breakthroughs on mineral extraction.

Ionic Rare Earths reports major strides in sustainable magnet recycling and heavy rare earth projects, backed by strategic partnerships and a sharp reduction in losses.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Linius Technologies embarks on a strategic transformation under CEO Ben Taverner, focusing on operational restructuring, AI-enhanced SaaS products, and market expansion beyond sports to achieve breakeven by June 2026.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.